ERT Launches Phase I Site Certification Program

Published on: 

Applied Clinical Trials

ERT announced it has launched a certification program for Phase I investigative sites conducting cardiac safety studies. This program trains sites to collect precise cardiac safety data by using ERT’s proprietary Expert Precision QT approach so that trial sponsors and CROs can determine the safety of their compounds earlier in development, which can save significant time and money. 


Read the full release here.